MedTrace Logo

Impact of Blueberry Consumption on Gastrointestinal Health

NCT03934177 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2023-03-22

No results posted yet for this study

Summary

This study will evaluate the impact of blueberry consumption on markers of gastrointestinal health including gut microbiota, intestinal permeability, and gut-derived inflammation in those vulnerable to a unhealthy gut milieu. All participants will consume a blueberry powder and a placebo in this crossover study.

Conditions

Interventions

DIETARY_SUPPLEMENT

Blueberry powder

Dried, powdered blueberries will be consumed at 24 g/day in two divided doses at least 4 hours apart.

DIETARY_SUPPLEMENT

Placebo powder

A placebo consisting maltodextrin will be consumed at 24 g/day in two divided doses at least 4 hours apart.

Sponsors & Collaborators

  • Rush University Medical Center

    collaborator OTHER

  • University of Nebraska

    collaborator OTHER

  • University of Nebraska Lincoln

    lead OTHER

Principal Investigators

  • Heather E Rasmussen, PhD · University of Nebraska Lincoln

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-26
Primary Completion
2023-03-02
Completion
2023-03-02

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03934177 on ClinicalTrials.gov